Alpine Immune Sciences Inc

NASDAQ:ALPN  
12.00
+0.20 (+1.70%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)291.64M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$6.67 Million
Adjusted EPS-$0.36
See more estimates
10-Day MA$12.10
50-Day MA$11.97
200-Day MA$10.64
See more pivots

Alpine Immune Sciences Inc Stock, NASDAQ:ALPN

188 East Blaine Street, Suite 200, Seattle, Washington 98102
United States of America
Phone: +1.206.788.4545
Number of Employees: 57

Description

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases; immuno-oncology; and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.